These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 3819786

  • 1. Ultrastructural localization of glucocerebrosidase in cultured Gaucher's disease fibroblasts by immunocytochemistry.
    Willemsen R, van Dongen JM, Ginns EI, Sips HJ, Schram AW, Tager JM, Barranger JA, Reuser AJ.
    J Neurol; 1987 Jan; 234(1):44-51. PubMed ID: 3819786
    [Abstract] [Full Text] [Related]

  • 2. Determination of Gaucher's disease phenotypes with monoclonal antibody.
    Ginns EI, Tegelaers FP, Barneveld R, Galjaard H, Reuser AJ, Brady RO, Tager JM, Barranger JA.
    Clin Chim Acta; 1983 Jul 15; 131(3):283-7. PubMed ID: 6883722
    [Abstract] [Full Text] [Related]

  • 3. An immunoelectron microscopic study of glucocerebrosidase in type 1 Gaucher's disease spleen.
    Willemsen R, van Dongen JM, Aerts JM, Schram AW, Tager JM, Goudsmit R, Reuser AJ.
    Ultrastruct Pathol; 1988 Jul 15; 12(5):471-8. PubMed ID: 3194992
    [Abstract] [Full Text] [Related]

  • 4. Molecular weight characterization of beta-D-glucocerebrosidase in mononuclear white blood cells in Gaucher's disease.
    Pirruccello S, Barranger JA, Barton NW, Brady RO, Ginns EI.
    Biochem Med; 1984 Feb 15; 31(1):73-9. PubMed ID: 6743300
    [Abstract] [Full Text] [Related]

  • 5. Gaucher disease: the effects of phosphatidylserine on glucocerebrosidase from normal and Gaucher fibroblasts.
    Choy FY.
    Hum Genet; 1984 Feb 15; 67(4):432-6. PubMed ID: 6436168
    [Abstract] [Full Text] [Related]

  • 6. Gaucher's disease in the presence of normal glucocerebrosidase activity.
    Schofield DE, Scott CR, Lage JM, Farrell DF.
    Hum Pathol; 1992 May 15; 23(5):588-92. PubMed ID: 1568755
    [Abstract] [Full Text] [Related]

  • 7. Infantile Gaucher's disease: glucocerebrosidase deficiency in peripheral blood leukocytes and cultured fibroblasts.
    Sengers RC, Lamers KJ, Bakkeren JA, Schretlen ED, Trijbels JM.
    Neuropadiatrie; 1975 Nov 15; 6(4):377-82. PubMed ID: 241947
    [Abstract] [Full Text] [Related]

  • 8. Impaired trafficking of mutants of lysosomal glucocerebrosidase in Gaucher's disease.
    Schmitz M, Alfalah M, Aerts JM, Naim HY, Zimmer KP.
    Int J Biochem Cell Biol; 2005 Nov 15; 37(11):2310-20. PubMed ID: 15982918
    [Abstract] [Full Text] [Related]

  • 9. Acquired Gaucher's cells in Hodgkin's disease.
    Lee KS, Tobin MS, Chen KT, Ahmed F, Gomez-Leon G.
    Am J Med; 1982 Aug 15; 73(2):290-4. PubMed ID: 7114083
    [Abstract] [Full Text] [Related]

  • 10. Sulfogalactocerebroside and bis-(monoacylglyceryl)-phosphate as activators of spleen glucocerebrosidase.
    Prence EM, Garrett KO, Panitch H, Basu A, Glew RH, Wherrett JR, Huterer S.
    Clin Chim Acta; 1986 Apr 30; 156(2):179-89. PubMed ID: 3085988
    [Abstract] [Full Text] [Related]

  • 11. Activators of spleen glucocerebrosidase from controls and patients with various forms of Gaucher's disease.
    Basu A, Glew RH, Daniels LB, Clark LS.
    J Biol Chem; 1984 Feb 10; 259(3):1714-9. PubMed ID: 6693432
    [Abstract] [Full Text] [Related]

  • 12. A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease.
    Tsuji S, Choudary PV, Martin BM, Stubblefield BK, Mayor JA, Barranger JA, Ginns EI.
    N Engl J Med; 1987 Mar 05; 316(10):570-5. PubMed ID: 2880291
    [Abstract] [Full Text] [Related]

  • 13. Incorporation of glucocerebrosidase into Gaucher's disease monocytes in vitro.
    Dale GL, Kuhl W, Beutler E.
    Proc Natl Acad Sci U S A; 1979 Jan 05; 76(1):473-5. PubMed ID: 284362
    [Abstract] [Full Text] [Related]

  • 14. Lysosome-targeted octadecyl-rhodamine B-liposomes enhance lysosomal accumulation of glucocerebrosidase in Gaucher's cells in vitro.
    Thekkedath R, Koshkaryev A, Torchilin VP.
    Nanomedicine (Lond); 2013 Jul 05; 8(7):1055-65. PubMed ID: 23199221
    [Abstract] [Full Text] [Related]

  • 15. Comparison of N-acyl phosphatidylethanolamines with different N-acyl groups as activators of glucocerebrosidase in various forms of Gaucher's disease.
    Basu A, Prence E, Garrett K, Glew RH, Ellingson JS.
    Arch Biochem Biophys; 1985 Nov 15; 243(1):28-34. PubMed ID: 3933429
    [Abstract] [Full Text] [Related]

  • 16. Enzymic differentiation of neurologic and nonneurologic forms of Gaucher's disease.
    Glew RH, Daniels LB, Clark LS, Hoyer SW.
    J Neuropathol Exp Neurol; 1982 Nov 15; 41(6):630-41. PubMed ID: 6813430
    [Abstract] [Full Text] [Related]

  • 17. The subcellular localization of soluble and membrane-bound lysosomal enzymes in I-cell fibroblasts: a comparative immunocytochemical study.
    van Dongen JM, Willemsen R, Ginns EI, Sips HJ, Tager JM, Barranger JA, Reuser AJ.
    Eur J Cell Biol; 1985 Nov 15; 39(1):179-89. PubMed ID: 2935398
    [Abstract] [Full Text] [Related]

  • 18. Lysosomal trafficking defects link Parkinson's disease with Gaucher's disease.
    Wong YC, Krainc D.
    Mov Disord; 2016 Nov 15; 31(11):1610-1618. PubMed ID: 27619775
    [Abstract] [Full Text] [Related]

  • 19. Activation of p38 Mitogen-Activated Protein Kinase in Gaucher's Disease.
    Kitatani K, Wada M, Perry D, Usui T, Sun Y, Obeid LM, Yaegashi N, Grabowski GA, Hannun YA.
    PLoS One; 2015 Nov 15; 10(8):e0136633. PubMed ID: 26312487
    [Abstract] [Full Text] [Related]

  • 20. Gaucher's disease and chronic lymphocytic leukemia. Possible pathogenetic link between Gaucher's disease and B-cell proliferations?
    Fox H, McCarthy P, André-Schwartz J, Shoenfeld Y, Miller KB.
    Cancer; 1984 Jul 15; 54(2):312-4. PubMed ID: 6609761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.